Seok Yun Kang

机构：University of Suwon, Ajou University Hospital, Ajou University · ORCID：0000-0002-4995-9912

发表论文 216 篇 · 总被引 4184 次 · h-index 32

代表论文

• Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study (2025 · Journal of Clinical Oncology · 被引 45)
• Palbociclib plus endocrine therapy versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (Young-PEARL): overall survival analysis of a randomised, open-label, phase 2 study (2025 · The Lancet Oncology · 被引 12)
• Nivolumab Plus Chemotherapy versus Placebo Plus Chemotherapy in Korean Patients with HER2-Negative, Untreated, Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction Cancer: Subgroup Analysis of a Randomized, Multicenter, Double-Blind Phase 3 Trial (ATTRACTION-4) (2025 · Cancer Research and Treatment · 被引 3)
• Cooperative ETS transcription factors are required for lymphatic endothelial cell integrity and resilience (2025 · Journal of Clinical Investigation · 被引 2)
• Platform study of circulating tumor DNA directed adjuvant chemotherapy in colon cancer (CLAUDIA colon cancer, KCSG CO22-12) (2025 · BMC Cancer · 被引 2)
• Analysis of outcomes according to start timing of adjuvant chemotherapy in patients with gastric cancer: a retrospective nationwide cohort study (2025 · The Oncologist · 被引 2)